Helen Louise Collins - 28 Jul 2021 Form 3 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Marc Grasso, Attorney-in-fact for Helen Collins
Issuer symbol
KURA
Transactions as of
28 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 17:14:35 UTC
Next filing
23 Jun 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.